Local police accused the same legal assistance group targeted by Joseph McCarthy of being part of a vast antifa conspiracy.
STUTTGART, Germany — Austria scrambled fighter planes on back-to back days to intercept U.S. Air Force reconnaissance aircraft traveling through its airspace, the country’s defense ministry said this ...
The top-eight sides sit equal on points while every side in the competition has now tasted victory following an intriguing ...
Some of the in-run events in Marathon, like Intercept, have some light puzzle-solving elements to them. That doesn’t mean Intercept is particularly difficult to complete, but it’s risky to attempt if ...
Faris Tanyos is a news editor for CBSNews.com, where he writes and edits stories and tracks breaking news. He previously worked as a digital news producer at several local news stations up and down ...
The end-game of The First Descendant thrives largely on its Void Intercept Battles. Throughout the main campaign of this game, there are story bosses from the Vulgas like Eterllick, but the Void ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The intercept, collected by a foreign intelligence service and shared ...
U.S. fighter jets were scrambled Wednesday to identify and intercept four Russian warplanes flying near Alaska, the North American Aerospace Defense Command said in a statement. NORAD said two Russian ...
While the path for any drug to go from lab research to commercialization takes years, Intercept Pharmaceuticals now stands as another example that a product’s market exit can also be long and winding.
Please provide your email address to receive an email when new articles are posted on . Intercept has voluntarily withdrawn its lone product, Ocaliva, from U.S. market for primary biliary cholangitis.
Alongside the withdrawal request, the FDA has also placed a clinical hold on all Intercept clinical trials involving obeticholic acid. Intercept Pharmaceuticals has decided to voluntarily withdraw ...
Sept 11 (Reuters) - Intercept Pharmaceuticals said on Thursday it is withdrawing its liver disease drug from the U.S. market following a request from the Food and Drug Administration. This comes as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results